Deoxycholic acid, an endogenously produced bile acid, has emerged as a pioneering non‐surgical treatment for reducing submental fat. By selectively inducing adipocytolysis—the breakdown of fat ...

REROVOT, Israel, March 3, 2025 /PRNewswire/ -- Raziel Therapeutics, a pharmaceutical company developing next-generation novel prescription products for the medical aesthetics market, announces phase 3 ...

Cutia Therapeutics (HK:2487) has released an update. Cutia Therapeutics has announced the completion of a Phase II clinical trial for CU-20401, a novel drug targeting submental fat reduction. This ...

Please provide your email address to receive an email when new articles are posted on . After 12 weeks of application, overall skin firmness improved by 61% from baseline. Skin texture improved by 59% ...